Trial
NCT03946891
Nebulized Furosemide in Premature Infants With Bronchopulmonary Dysplasia - A Cross Over Pilot Study of Its Efficacy and Safety
Early Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
NYU Langone Health
Collaborators
—
Condition
Premature Birth
Intervention
Inhaled Furosemide
Why stopped
The study was stopped due to lack of study staff and inability to enroll subjects into the study due to restrictive inclusion criteria.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-25